Is AtriCure, Inc. (ATRC) Stock a Sell after Justin Noznesky’s Insider Trade?; Motorcar Parts America (MPAA)’s Sentiment Is 1.27

February 17, 2018 - By Marie Mckinney

On February 16, 2018, the SVP – Mktg & Business Develop of Atricure Inc, Mr. Justin Noznesky, sold amount of company shares – 4,000, totalling $68,120 US Dollars, based on $17.0 per every share. Justin Noznesky right now holds 124,997 shares or 0.36% of Atricure Inc’s market cap.

Motorcar Parts of America, Inc. manufactures, remanufactures, and distributes automotive aftermarket parts. The company has market cap of $437.94 million. The firm offers rotating electrical products, including alternators and starters; wheel hub assemblies and bearings; brake master cylinders; and other products, such as turbochargers and brake power boosters for import and domestic cars, light trucks, heavy duty, agricultural, and industrial applications. It has a 26.36 P/E ratio. It sells its products to automotive retail chain stores and warehouse distributors; and the professional repair market, as well as various automobile manufacturers for their aftermarket programs and warranty replacement programs in North America.

The stock decreased 3.93% or $0.94 during the last trading session, reaching $22.96. About 160,572 shares traded. Motorcar Parts of America, Inc. (MPAA) has risen 7.21% since February 17, 2017 and is uptrending. It has underperformed by 9.49% the S&P500.

Fine Capital Partners L.P. holds 5.59% of its portfolio in Motorcar Parts of America, Inc. for 1.81 million shares. Euclidean Technologies Management Llc owns 51,354 shares or 1.45% of their US portfolio. Moreover, Ashford Capital Management Inc has 1.41% invested in the company for 297,800 shares. The Minnesota-based Summit Creek Advisors Llc has invested 1.28% in the stock. Perritt Capital Management Inc, a Illinois-based fund reported 159,250 shares.

AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company has market cap of $584.68 million. The firm offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures, such as coronary artery bypass grafting and/or valve replacement or repair; COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy; and EPi-Sense guided coagulation system used for the temporary cardiac signal sensing and recording during surgery. It currently has negative earnings. It also provides SUBTLE cannula, an access device and conduit for the ablation device and endoscope to enable a closed chest endoscopic approach; multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable physicians to create an expanded cardiac ablation lesion set.

Investors sentiment increased to 2.03 in 2017 Q3. Its up 0.78, from 1.25 in 2017Q2. It increased, as 9 investors sold AtriCure, Inc. shares while 21 reduced holdings. 23 funds opened positions while 38 raised stakes. 26.77 million shares or 5.51% more from 25.37 million shares in 2017Q2 were reported. Sei Investments Commerce stated it has 0% of its portfolio in AtriCure, Inc. (NASDAQ:ATRC). Voya Inv Mngmt Lc has 0% invested in AtriCure, Inc. (NASDAQ:ATRC) for 17,158 shares. Vanguard Gru Inc accumulated 1.47M shares or 0% of the stock. Bnp Paribas Arbitrage has 3,194 shares. Cortina Asset Mgmt Ltd Liability Co invested 0.4% in AtriCure, Inc. (NASDAQ:ATRC). Neuberger Berman Ltd Liability reported 900,296 shares or 0.03% of all its holdings. State Street has invested 0% in AtriCure, Inc. (NASDAQ:ATRC). Morgan Stanley reported 96,445 shares. First Manhattan stated it has 0% in AtriCure, Inc. (NASDAQ:ATRC). Weiss Multi reported 0.02% of its portfolio in AtriCure, Inc. (NASDAQ:ATRC). Tudor Inv Et Al holds 0.01% of its portfolio in AtriCure, Inc. (NASDAQ:ATRC) for 17,694 shares. Portfolio Solutions Limited Liability Company holds 0% in AtriCure, Inc. (NASDAQ:ATRC) or 235 shares. 560,701 were reported by Emerald Advisers Pa. 63,400 are owned by Arrowstreet Cap L P. Fmr Limited owns 5.15 million shares or 0.01% of their US portfolio.

The stock decreased 1.51% or $0.26 during the last trading session, reaching $16.96. About 165,261 shares traded. AtriCure, Inc. (NASDAQ:ATRC) has risen 53.35% since February 17, 2017 and is uptrending. It has outperformed by 36.65% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>